Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Sicinski

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Cancer Cell|March 19, 2020
Chemotherapy and CDK4/6 Inhibition in Cancer Treatment: Timing Is EverythingAnne Fassl, Piotr Sicinski
Open Biology|January 9, 2020
A kinase of many talents: non-neuronal functions of CDK5 in development and diseaseSamanta Sharma, Piotr Sicinski
Nature Reviews. Cancer|January 28, 2017
Cell cycle proteins as promising targets in cancer therapyTobias Otto, Piotr Sicinski
The Journal of Cell Biology|February 23, 2024
PC4: A new regulator of cyclin D1 transcript levelsAnne Fassl, Piotr Sicinski
Cancer Cell|August 17, 2013
The kinase-independent, second life of CDK6 in transcriptionTobias Otto, Piotr Sicinski
Cell Cycle (Georgetown, Tex.)|January 17, 2004
Mammalian cell cycles without cyclin E-CDK2Qunyan Yu, Piotr Sicinski
Cell Cycle (Georgetown, Tex.)|March 2, 2005
Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexesKatarzyna Kozar, Piotr Sicinski
Cell Cycle (Georgetown, Tex.)|April 4, 2013
Differences in regulation and function of E-cyclins in human cancer cellsYan Geng, Piotr Sicinski
Molecular Cancer Therapeutics|July 15, 2025
Targeting Transcriptional Cyclin-Dependent Kinases in CancerAleksandra Kolodziejczyk, Piotr Sicinski
Oncotarget|April 9, 2013
Unexpected outcomes of CDK4/6 inhibitionYoon Jong Choi, Piotr Sicinski
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Cancer Cell|March 19, 2020
Chemotherapy and CDK4/6 Inhibition in Cancer Treatment: Timing Is EverythingAnne Fassl, Piotr Sicinski
Open Biology|January 9, 2020
A kinase of many talents: non-neuronal functions of CDK5 in development and diseaseSamanta Sharma, Piotr Sicinski
Nature Reviews. Cancer|January 28, 2017
Cell cycle proteins as promising targets in cancer therapyTobias Otto, Piotr Sicinski
The Journal of Cell Biology|February 23, 2024
PC4: A new regulator of cyclin D1 transcript levelsAnne Fassl, Piotr Sicinski
Cancer Cell|August 17, 2013
The kinase-independent, second life of CDK6 in transcriptionTobias Otto, Piotr Sicinski
Cell Cycle (Georgetown, Tex.)|January 17, 2004
Mammalian cell cycles without cyclin E-CDK2Qunyan Yu, Piotr Sicinski
Cell Cycle (Georgetown, Tex.)|March 2, 2005
Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexesKatarzyna Kozar, Piotr Sicinski
Cell Cycle (Georgetown, Tex.)|April 4, 2013
Differences in regulation and function of E-cyclins in human cancer cellsYan Geng, Piotr Sicinski
Molecular Cancer Therapeutics|July 15, 2025
Targeting Transcriptional Cyclin-Dependent Kinases in CancerAleksandra Kolodziejczyk, Piotr Sicinski
Oncotarget|April 9, 2013
Unexpected outcomes of CDK4/6 inhibitionYoon Jong Choi, Piotr Sicinski
Pageof 12